Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Paclitaxel/Carboplatin + IP Paclitaxel for Advanced Ovarian Cancer
NCT00919984Phase 2Terminated
- Sponsor
- Korea Cancer Center Hospital
- Start
- May 2007
- Primary completion
- Oct 2010
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in epithelial ovarian cancer (EOC), primary peritoneal carcinoma (PPC), fallopian tube cancer (PFTC), sponsored by Korea Cancer Center Hospital. Started May 2007; status: terminated.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
epithelial ovarian cancer (EOC)primary peritoneal carcinoma (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00919984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919984.